CONTEXT
Type 2 diabetes (T2D) affects nearly half a billion people worldwide, historically in the northern hemisphere and recently in developing countries due to a massive rural exodus. Health expenditure amounts to more than 590 billion euros, including 30 billion euros in active pharmaceutical ingredients.
DESCRIPTION
The laboratory demonstrated, in vivo:
1) the preventive effect against type 2 diabetes of plant extracts in healthy rats fed a high fat and sucrose diet causing the onset of T2D,
2) the therapeutic effect in Zücker rats suffering from incurable type 2 diabetes.
Blood glucose, insulin, glucose tolerance, insulin sensitivity, triglycerides, cholesterol and lean to fat mass ratio are either preserved (healthy rats) or improved (T2D sick rats).
No effects were observed in healthy rats with a normal diet.
COMPETITIVE ADVANTAGES
MARKETS & APPLICATIONS
Pharmaceutical and Dietary supplements:
DEVELOPMENT STAGE
TRL 4: model validated in vivo
Active ingredients under characterization
INTELLECTUAL PROPERTY
French patent application in progress
TARGET PARTNERSHIP
Patent licensing
CONTACT
Thomas BLUM
Business Developer
+33 (0)6 17 06 68 07
thomas.blum@sayens.fr